In last trading session, Moleculin Biotech Inc (NASDAQ:MBRX) saw 0.49 million shares changing hands with its beta currently measuring 2.09. Company’s recent per share price level of $1.13 trading at -$0.03 or -2.59% at ring of the bell on the day assigns it a market valuation of $15.03M. That closing price of MBRX’s stock is at a discount of -683.19% from its 52-week high price of $8.85 and is indicating a premium of 64.6% from its 52-week low price of $0.40. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.86 million shares which gives us an average trading volume of 5.77 million if we extend that period to 3-months.

Moleculin Biotech Inc (NASDAQ:MBRX) trade information

Upright in the red during last session for losing -2.59%, in the last five days MBRX remained trading in the green while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $1.13 price level, adding 14.39% to its value on the day. Moleculin Biotech Inc’s shares saw a change of -33.53% in year-to-date performance and have moved 0.89% in past 5-day. Moleculin Biotech Inc (NASDAQ:MBRX) showed a performance of 169.05% in past 30-days. Number of shares sold short was 1.08 million shares which calculate 0.08 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 18.25% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 49.55% while estimates for its earnings growth in next 5 years are of 36.38%.

Moleculin Biotech Inc (NASDAQ:MBRX)’s Major holders

Insiders are in possession of 0.83% of company’s total shares while institution are holding 3.87 percent of that, with stock having share float percentage of 3.90%. Investors also watch the number of corporate investors in a company very closely, which is 3.87% institutions for Moleculin Biotech Inc that are currently holding shares of the company.

On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 30.31 shares of worth $34254.0 or 0.23% of the total outstanding shares. The later fund manager was in possession of 14.58 shares on Dec 31, 2024 , making its stake of worth around $16470.0 in the company or a holder of 0.11% of company’s stock.